Basic info
Industry
biotechnology research
Sectors
Biotechnology
immune engineering
immunogenicity risk assessment
immunogenicity screening
computational immunology
engineering therapeutic proteins
deimmunization
Pharmaceutical
in silico prediction
Biologics Research and Development
Analytics
Animal Health Vaccines
Cancer vaccines
Health Care
Deimmunization
vaccine design
Date founded
1998
Funding rounds raised
Total raised
$1.5M
from 8 investors over 8 rounds
E
EpiVax, Inc. raised $600K on September 12, 2016
Investors: National Institutes of Health
E
EpiVax, Inc. raised $55K on November 1, 2012
Investors: GBS|CIDP Foundation International
E
EpiVax, Inc. raised $300K on September 5, 2012
Investors: National Institutes of Health
E
EpiVax, Inc. raised $1.5M on April 9, 2012
Investors: National Institutes of Health
E
EpiVax, Inc. raised $458K on January 25, 2011
Investors: National Institutes of Health
E
EpiVax, Inc. raised $390K on November 26, 2008
Investors: National Institutes of Health
E
EpiVax, Inc. raised $600K on July 8, 2008
Investors: National Institutes of Health
E
EpiVax, Inc. raised $368K on February 28, 2007
Investors: National Institutes of Health